GSK Submits Pandemic Flu Vaccine Under EU Accelerated Review Program
Submission marks the first use of the European Medicines Agency’s “core dossier” accelerated review program.
Submission marks the first use of the European Medicines Agency’s “core dossier” accelerated review program.